Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > PPPV per presentation proforma value

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Nov 18, 2021 10:07am

87 Views

Post# 34140342

RE:PPPV per presentation proforma value

thanks MM

I always appreciate your posts like this one, especially during the long periods of share price Rot that shareholders have to endure here.

Stocktree you were right and I was wrong. The EDT bashers always seem to know where the price is headed. Always! I find that very telling.

<< Previous

Bullboard Posts

Next >>

Stockhouse DealRoom opens new Australian opportunities